BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Business

  Vical Incorporated Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines

  November 2, 2012

   · 

  1 min read
• Business

  Amarin Corporation PLC to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012

  November 2, 2012

   · 

  1 min read
• Policy

  Nanosphere, Inc.'s Bloodstream Infection Test Designated Moderate Complexity by FDA

  November 2, 2012

   · 

  1 min read
• Bio NC

  TranS1 Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference

  November 2, 2012

   · 

  1 min read
• Business

  Oculus Innovative Sciences, Inc. Reports Record Revenues of $4.5 Million for the Second Quarter of Fiscal 2013

  November 2, 2012

   · 

  1 min read
• Drug Development

  AlphaCore Pharma Granted Orphan Drug Designation for ACP-501 (rhLCAT) by European Medicines Agency

  November 2, 2012

   · 

  1 min read
• Business

  Dendreon Corporation Announces Third Quarter 2012 Results

  November 2, 2012

   · 

  1 min read
• Pharm Country

  Bristol-Myers Squibb Company Receives Positive Decision From National Institute for Clinical Excellence (NICE) for YERVOY® (ipilimumab)

  November 2, 2012

   · 

  1 min read
• Business

  Furiex Pharmaceuticals, Inc. Reports Third Quarter 2012 Financial Resultsf

  November 2, 2012

   · 

  1 min read
• Policy

  Merck & Co., Inc. Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit Related to Vioxx

  November 2, 2012

   · 

  1 min read